After 28 years of leadership, M. Marsel Mesulam, MD, has announced that he will be stepping down as director of the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease; he will be succeeded by Robert Vassar, PhD.
Northwestern Medicine investigators have discovered that outer mitochondrial membrane proteins regulate crosstalk between mitochondria and lysosomes, findings that have implications for many diseases.
Dimitri Krainc, MD, PhD, chair and Aaron Montgomery Ward Professor of Neurology, has been elected to the National Academy of Medicine.
Investigators have discovered novel cellular pathways behind chemotherapy-resistant glioblastoma cells and a potential biomarker, paving the way for new therapeutic targets.
Exposure to light during sleep was associated with obesity, diabetes and high blood pressure in older adults, according to a recent study.
A new Northwestern Medicine study has identified how ketamine works so quickly, and how it might be adapted without side effects.
Investigators have discovered a new method to determine whether individual genetic variants in the epilepsy-associated gene SZT2 cause the neurodevelopmental disorder, according to a Northwestern Medicine study.
Most non-hospitalized COVID-19 “long-haulers” at the Northwestern Medicine Neuro COVID-19 Clinic continued to experience symptoms including brain fog, dizziness and fatigue 15 months after disease onset, according to a new study.
The Mesulam Center for Cognitive Neurology and Alzheimer’s Disease held the 28th annual Alzheimer Day on May 5, returning to campus for the first time in three years.
The Michael J. Fox Foundation for Parkinson’s Research has chosen Northwestern to receive an Edmond J. Safra Fellowship in Movement Disorders to train a movement disorder clinician-investigator.